Compass Pathways Announces Strategic Collaboration with Radial
Compass Pathways partners with Radial Health to inform scalable COMP360 psilocybin delivery models and patient experience innovation across U.S. psychiatry clinics. Compass Pathways Radial collaboration marks a calculated step in the company’s long-term effort to define how regulated psychedelic therapies…
Sinovac Receives Nasdaq Notice for Late Filing of 2025 Half-Year Report
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report Sinovac Biotech Ltd. a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq…
Immunotherapy Drugs Market – Global Analysis 2025 with Revenue History and 2030 Forecast
ResearchAndMarkets.com has added the report “Immunotherapy Drugs: Global Markets” to its portfolio, providing an in-depth analysis of one of the fastest-growing segments in the pharmaceutical industry. The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025…
Europe Image-Guided Drug Delivery Market Outlook, 2025–2035
ResearchAndMarkets.com has announced the addition of a new report titled “Europe Image-Guided Drug Delivery Market: Focus on Technology Type, Application, End User, and Country Analysis (2025–2035).” The report provides a comprehensive assessment of the rapidly evolving image-guided drug delivery (IGDD)…
Global AI Digital Pathology Market Outlook, 2025–2035
ResearchAndMarkets.com has announced the addition of a comprehensive new market intelligence report titled “AI-Based Digital Pathology Market: Industry Trends and Global Forecasts Through 2035.” The report delivers an in-depth evaluation of one of the fastest-evolving segments of healthcare diagnostics, highlighting…
Medcare UAE Treats First International SMA Patient Using Intrathecal Gene Therapy
Medcare Expands Access to Breakthrough Intrathecal Gene Therapy for Spinal Muscular Atrophy, Treats First International Older Patient Medcare Women & Children Hospital has reached a significant milestone in the treatment of Spinal Muscular Atrophy (SMA) by successfully administering a newly…
Vicarious Surgical Taps Partner to Streamline Software Operations
Vicarious Surgical Enters Strategic Software Engineering Partnership to Enhance Execution, Predictability, and Operational Efficiency Vicarious Surgical, a next-generation robotics technology company focused on transforming robotic surgery to improve patient outcomes and expand access to minimally invasive procedures, today announced that…
EU Veterinary Pharmacovigilance Introductory Training (Mar 2026)
Introductory EU Veterinary Drug Safety Course (Mar 2026) The “Introduction to Veterinary Pharmacovigilance Training Course (March 9–10, 2026)” has been added to the growing portfolio of professional training programs available through ResearchAndMarkets.com. This comprehensive two-day course is designed to deliver…
Generational Group Advises Swift Health Medical Group on Sale to Private Practice
Swift Health Medical Group Sold to Private Medical Practice with Generational Group Advisory Generational Group, a nationally recognized mergers and acquisitions advisory firm serving privately held businesses, announced the successful sale of Swift Health Medical Group, an Atlanta-based urgent care…
MolinaCares and Molina Healthcare Donate $187K to Nevada Food Banks
As food insecurity continues to rise across Nevada, The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Nevada (“Molina”), has announced a significant investment to support communities struggling to meet basic nutritional needs. Through grants totaling $187,000, the organizations…
Global Motion Sickness Treatment Market Outlook, 2025–2032
$922M Motion Sickness Treatment Market Outlook (2025–2032) The global Motion Sickness Treatment Market continues to demonstrate steady expansion as evolving patient needs, technological innovation, and targeted pharmaceutical advancements reshape the landscape of care. According to the newly released report, “Motion…
GenSight Biologics Secures Israeli Authorization for Early Access to LUMEVOQ
Israel Grants Regulatory Authorization for Early Access Use of GS010/LUMEVOQ in ND4-LHON Patients GenSight Biologics, a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapies for retinal neurodegenerative diseases and disorders of the central nervous system, has…